Updates
Clarification relating to an article on Glenmark published in today's edition of Indian Express In response to an article published by the Indian Express in its today's edition with respect to Glenmark's Ankleshwar plant receiving observations from the USFDA during its inspection in December, 2016. In this regard, Glenmark would like to state that its Ankleshwar plant has received the EIR (Establishment Inspection Report) yesterday. The EIR...
Glenmark gets USFDA nod to start phase-II clinical trials for respiratory drug
Glenmark is allowed to administer respiratory drug tiotropium bromide through a nebuliser to patients with chronic obstructive pulmonary disease Glenmark ties up with Evestra to develop contraceptive
The companies will file for product approval in FY19 Press Release
Sub:- Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing
Glenmark Pharma's Ankleshwar plant gets 4 FDA observations
Glenmark Pharmaceuticals' Active Pharmaceutical Ingredients plant at Ankleshwar was inspected by the United States Food and Drug Administration in December 2016 Updates
Glenmark Pharmaceuticals Ltd vide its letter dated February 20, 2017 has informed BSE about the following :"We have received today a query from the media regarding Glenmark receiving the observations on its Ankleshwar Plant in Gujarat pursuant to the USFDA Audit.Our response which will be sent to the media agency is given below:... Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Oppenheimer Funds, Inc (F.I.I) Glenmark Pharma gets earnings boost
The shares of Glenmark Pharmaceuticals surged about 7 per cent in early trades on Friday on the back of strong third-quarter (Q3) earnings. The stock recorded a high of 970 and has come-off from... Outcome of Nomination & Remuneration Committee Meeting
Glenmark Pharmaceuticals Ltd has informed BSE that the Nomination & Remuneration Committee of the Company, at its meeting held on February 02, 2017 has allotted 41,875 stock options and cancelled 20,938 stock options pursuant to Employee Stock Options Scheme, 2016.The Options granted under Employee Stock Options Scheme, 2016 and exercise thereof is subject to all applicable laws.